Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Operating Expenses | 110 | 108 | 147 | 112 | 140 |
| Operating Income | -110 | -108 | -147 | -112 | -140 |
| Interest Expense | 0 | 6 | 0 | 0 | 0 |
| Other Income | 24 | 34 | -363 | -259 | 151 |
| Pre-tax Income | -86 | -80 | -510 | -370 | 11 |
| Net Income Continuous | -86 | -80 | -510 | -370 | 11 |
| Net Income | $-86 | $-80 | $-510 | $-370 | $11 |
| EPS Basic Total Ops | 0.00 | 0.00 | 6.10 | -3.05 | 0.00 |
| EPS Basic Continuous Ops | -0.45 | -0.42 | 5.38 | -1.96 | 0.06 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 6.10 | -3.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.45 | -0.42 | 5.38 | -1.96 | 0.06 |
| EBITDA(a) | $-110 | $-107 | $-147 | $-111 | $-140 |